304 related articles for article (PubMed ID: 15075090)
1. Anticoagulation in the antiphospholipid syndrome.
Casais P; Alberto MF; Gennari LC; Grosso SH; Meschengieser SS; Lazzari MA
Haematologica; 2004 Apr; 89(4):503-4. PubMed ID: 15075090
[TBL] [Abstract][Full Text] [Related]
2. The management of thrombosis in the antiphospholipid-antibody syndrome.
Khamashta MA; Cuadrado MJ; Mujic F; Taub NA; Hunt BJ; Hughes GR
N Engl J Med; 1995 Apr; 332(15):993-7. PubMed ID: 7885428
[TBL] [Abstract][Full Text] [Related]
3. Thrombosis in systemic lupus erythematosus: risk and protection.
Burgos PI; Alarcón GS
Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1541-9. PubMed ID: 19954316
[TBL] [Abstract][Full Text] [Related]
4. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
5. Hemorrhagic complications of long-term anticoagulant therapy in 7 patients with systemic lupus erythematosus and antiphospholipid syndrome.
al-Sayegh FA; Ensworth S; Huang S; Stein HB; Klinkhoff AV
J Rheumatol; 1997 Sep; 24(9):1716-8. PubMed ID: 9292793
[TBL] [Abstract][Full Text] [Related]
6. Clinical manifestations and outcomes of antithrombotic treatment of the Tan Tock Seng Hospital Singapore antiphospholipid syndrome cohort.
Tan BE; Thong BY; Shivananda S; Han WW; Chng HH
Lupus; 2009 Jul; 18(8):752-8. PubMed ID: 19502274
[TBL] [Abstract][Full Text] [Related]
7. Venous thrombosis in the antiphospholipid syndrome.
Farmer-Boatwright MK; Roubey RA
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):321-5. PubMed ID: 19228605
[TBL] [Abstract][Full Text] [Related]
8. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5.
Ruiz-Irastorza G; Khamashta MA; Hunt BJ; Escudero A; Cuadrado MJ; Hughes GR
Arch Intern Med; 2002 May; 162(10):1164-9. PubMed ID: 12020188
[TBL] [Abstract][Full Text] [Related]
9. Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.
Cohen H; Doré CJ; Clawson S; Hunt BJ; Isenberg D; Khamashta M; Muirhead N;
Lupus; 2015 Sep; 24(10):1087-94. PubMed ID: 25940537
[TBL] [Abstract][Full Text] [Related]
10. Catastrophic antiphospholipid antibody syndrome in pediatric systemic lupus erythematosus.
Falcini F; Taccetti G; Ermini M; Trapani S; Matucci Cerinic M
J Rheumatol; 1997 Feb; 24(2):389-92. PubMed ID: 9035002
[TBL] [Abstract][Full Text] [Related]
11. Potential failure of the International Normalized Ratio (INR) System in the monitoring of oral anticoagulation in patients with lupus anticoagulants.
Della Valle P; Crippa L; Safa O; Tomassini L; Pattarini E; Vigano-D'Angelo S; Grazia Sabbadini M; D'Angelo A
Ann Med Interne (Paris); 1996 Sep; 147 Suppl 1():10-4. PubMed ID: 8952752
[TBL] [Abstract][Full Text] [Related]
12. [Pulmonary thromboembolism and deep venous thrombosis in the antiphospholipid syndrome--case report].
Vucićević-Trobok J; Bogdanov B; Trifković M
Med Pregl; 2003; 56(1-2):85-8. PubMed ID: 12793194
[TBL] [Abstract][Full Text] [Related]
13. Rebuttal to: strong lupus anticoagulant can influence the prothrombin time INR falsifying the follow up of oral anticoagulation.
Bailleul E; Van Vaerenbergh K; Lust A
Thromb Haemost; 2005 Sep; 94(3):687; author reply 688. PubMed ID: 16268495
[No Abstract] [Full Text] [Related]
14. Antiphospholipid antibody syndrome of systemic lupus erythematosus presenting as deep vein thrombosis.
Salim S; Salim KA
J Assoc Physicians India; 1992 Feb; 40(2):125-6. PubMed ID: 1629122
[TBL] [Abstract][Full Text] [Related]
15. Management of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancy.
Ruiz-Irastorza G; Khamashta MA
Ann N Y Acad Sci; 2005 Jun; 1051():606-12. PubMed ID: 16127001
[TBL] [Abstract][Full Text] [Related]
16. [Antiphospholipid antibody syndrome: a priori a contraindication to kidney transplantation?].
Rubenwolf P; Lopau K; Gerharz EW; Heidbreder E; Riedmiller H
Aktuelle Urol; 2007 Mar; 38(2):132-6. PubMed ID: 17390275
[TBL] [Abstract][Full Text] [Related]
17. [Portal thrombosis disclosing antiphospholipid syndrome. 2 cases].
Bouaniche M; Guédon C; Borg JY; Zalar A; Ducrotté P; Lerebours E
Gastroenterol Clin Biol; 1996; 20(10):897-900. PubMed ID: 8991150
[TBL] [Abstract][Full Text] [Related]
18. [Thrombosis and antiphospholipid antibodies in systemic lupus erythematosus with pediatric onset].
Lev M; Montes de Oca M; Meyer O
Arch Fr Pediatr; 1992 Apr; 49 Suppl 1():249-53. PubMed ID: 1449369
[No Abstract] [Full Text] [Related]
19. Effects of inherited thrombophilic mutations in an adolescent with antiphospholipid syndrome and systemic lupus erythematosus.
Higginbotham EA; Zimmerman SA; Howard TA; Schanberg L; Kredich D; Ware RE
J Rheumatol; 2001 Feb; 28(2):370-2. PubMed ID: 11246680
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic principles in systemic lupus erythematosis with phospholipid syndrome].
Reshetniak TM; Alekberova ZS; Nasonov EL; Nasonova VA
Ter Arkh; 1998; 70(5):83-7. PubMed ID: 9644754
[No Abstract] [Full Text] [Related]
[Next] [New Search]
